Pharma Journalist -

GSK plc has entered into a licensing agreement with Alfasigma S.p.A. granting the Italian pharmaceutical company exclusive global rights to develop, manufacture, and commercialize…
Read More...

The U.S. Food and Drug Administration has announced a new regulatory initiative aimed at accelerating the development of biosimilar medicines while reducing costs for drug manufacturers…
Read More...

Pharmaceutical company GSK plc has entered into a licensing agreement with Italian drugmaker Alfasigma S.p.A. granting the latter worldwide exclusive rights to develop, manufacture and…
Read More...

Clinical-stage biotechnology company NewcelX Ltd. has announced a collaborative research agreement with immunology-focused firm Eledon Pharmaceuticals aimed at advancing potential new…
Read More...

Biotechnology company Liberate Bio, Inc. has secured new intellectual property licenses aimed at advancing next-generation cell therapies that reprogram immune cells directly inside the…
Read More...

Biotechnology companies Akeso, Inc. and INOVIO have announced a clinical trial collaboration and supply agreement to evaluate a new combination immunotherapy approach for glioblastoma…
Read More...

Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA interference specialist Alnylam Pharmaceuticals aimed at identifying novel…
Read More...

Antibody-drug conjugate analytical development is entering a defining moment. As next-generation modalities, including bispecific ADCs, degrader conjugates, and dual-payload constructs,…
Read More...

BioMed Realty has announced that CordenPharma Colorado has signed a long-term lease for a new laboratory facility at Flatiron Park in Boulder, marking a significant expansion for the…
Read More...

Affinia Therapeutics has received Fast Track designation from the U.S. Food and Drug Administration for its investigational gene therapy candidate AFTX-201, a potential treatment for…
Read More...